These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 33074049)
1. Development of potential proteasome inhibitors against Tyagi R; Srivastava M; Jain P; Pandey RP; Asthana S; Kumar D; Raj VS J Biomol Struct Dyn; 2022 Mar; 40(5):2189-2203. PubMed ID: 33074049 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library. Tyagi R; Srivastava M; Singh B; Sharma S; Pandey RP; Asthana S; Kumar D; Raj VS J Biomol Struct Dyn; 2022; 40(19):8644-8654. PubMed ID: 33955331 [TBL] [Abstract][Full Text] [Related]
3. Identification of New Almeleebia TM; Shahrani MA; Alshahrani MY; Ahmad I; Alkahtani AM; Alam MJ; Kausar MA; Saeed A; Saeed M; Iram S Molecules; 2021 Apr; 26(8):. PubMed ID: 33923734 [No Abstract] [Full Text] [Related]
4. A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing. Dwivedi M; Mukhopadhyay S; Yadav S; Dubey KD Comput Biol Med; 2022 Jul; 146():105607. PubMed ID: 35617724 [TBL] [Abstract][Full Text] [Related]
5. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach. Uddin R; Zahra NU; Azam SS Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161 [TBL] [Abstract][Full Text] [Related]
6. In Silico Approach for Phytocompound-Based Drug Designing to Fight Efflux Pump-Mediated Multidrug-Resistant Mycobacterium tuberculosis. Biswas SS; Browne RB; Borah VV; Roy JD Appl Biochem Biotechnol; 2021 Jun; 193(6):1757-1779. PubMed ID: 33826064 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents. Lokesh BVS; Prasad YR; Shaik AB Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
10. Bioisosteric modification of Linezolid identified the potential Girase R; Ahmad I; Patel H J Biomol Struct Dyn; 2024; 42(4):2111-2126. PubMed ID: 37097976 [TBL] [Abstract][Full Text] [Related]